Blue Paradigm Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Blue Paradigm Pharmaceuticals Llp
Blue Paradigm Pharmaceuticals Llp (BPPL) is 3 Year, 8 Months old Limited Liability Partnership 14 May 2021. Its registered office is in Thane, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAX-0199
-
Incorporation Date
14 May 2021
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Mumbai
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Blue Paradigm Pharmaceuticals Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kedar Vidhwans
|
Designated Partner | 14-May-2021 | Current |
|
Avinash Negi
|
Designated Partner | 14-May-2021 | Current |
Financial Performance of Blue Paradigm Pharmaceuticals Llp.
Enhance accessibility to Blue Paradigm Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Paradigm Pharmaceuticals Llp?
Unlock access to Blue Paradigm Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sushma Technology Private LimitedKedar Vidhwans is a mutual person
-
Divine Laboratories Pvt. Ltd.Kedar Vidhwans is a mutual person
-
Flagship Biotech International Private LimitedKedar Vidhwans is a mutual person
-
Flagship Ingrevia Private Limited
Kedar Vidhwans is a mutual person
-
Brigid Wellness Private Limited
Kedar Vidhwans is a mutual person
-
Flagship Biotech Foundation
Kedar Vidhwans is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Blue Paradigm Pharmaceuticals Llp?
Unlock and access historical data on people associated with Blue Paradigm Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Paradigm Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Paradigm Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.